http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201270261-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201270261-A1
titleOfInvention SALI LENALIDOMIDE
abstract The present invention relates to acid addition salts of lenalidomide, wherein said acid has a pKa of less than 1 and is preferably selected from hydrochloric acid, hydrobromic acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid and p-toluenesulfonic acid, to methods for their preparation and use in medicine, and to clean the base of lenalidomide.
priorityDate 2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425013245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407907394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395

Total number of triples: 26.